Breaks Categories: Stock Spotlights

WednesdayJun 20, 2018 1:31 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Progresses in Hemp Cultivation

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is devoted to building a portfolio of hemp-focused businesses that aim to produce the ancient, versatile crop. An article discussing the company reads: “Global Hemp Group was founded in 2014 with Canadian headquarters in Vancouver, British Columbia, and additional base operations in Montreal and Los Angeles. Its hemp cultivation efforts are initially focused on the production of high quality sustainable raw materials and non-psychotropic cannabidiol (CBD) oil, as well as other cannabinoids, with no intoxicating effects. Global Hemp Group’s collaboration with other companies is an integral…

Continue Reading

FridayJun 15, 2018 3:09 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Positioned in Growing Markets with Novel Therapies and Groundbreaking Delivery Platform

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is positioned in rapidly-growing markets with innovative preventative therapies and a groundbreaking cannabidiol (“CBD”) drug delivery platform. An article discussing this reads, “Research has shown CBD to be non-psychoactive and to have anti-inflammatory, anti-anxiety and anti-emetic properties (http://cnw.fm/o5xXH). Following nasal administration, the formulations gel rapidly with mucosal tissue to facilitate direct nose-to-brain delivery of cannabinoids. The gel substantially improves bioavailability and provides controlled cannabinoid release, staying in the nasal passages for up to seven days.” To view the full article, visit http://cnw.fm/X4Koh About PreveCeutical Medical Inc. PreveCeutical is a health sciences…

Continue Reading

FridayJun 15, 2018 3:04 pm

CannabisNewsBreaks – Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Leveraging Proprietary Technology in Innovative Cannabinoid Product Pipeline

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is leveraging innovative technology to target pain and a number of chronic conditions. A recent article discussing this reads, “These proprietary technologies are deployed in the development of cannabidiol (CBD) and tetrahydrocannabinol (THC) based products. Pivot’s cannabinoid pipeline of pharmaceutical products includes two that use the Solmic drug delivery technology for cancer supportive care, targeting the relief of mucositis and chemotherapy-induced nausea and vomiting. The company has also deployed its Bi-Phasix™ delivery platform for the development of four products that target women’s sexual desire disorder, glaucoma, dysmenorrhea and dermatological conditions. Pivot’s…

Continue Reading

ThursdayJun 14, 2018 12:04 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Strategically Positioned for Growth in Cannabis Industry

Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) recently entered into a five-year semi-exclusive licensing agreement with GP Holdings LLC to develop a high performing cannabis beverage to be sold in California, a flourishing cannabis marketplace. A recent article discussing the company’s unique technology reads: “The semi-exclusive agreement gives LXRP the ability to offer other licensee partners the option of utilizing GP’s formulation and manufacturing expertise to produce cannabis-infused beverages throughout California. With the California cannabis-beverage market anticipated to be one of the largest edible product segments, LXRP is strategically positioned for continued growth within the cannabis industry.” To view the…

Continue Reading

ThursdayJun 14, 2018 10:27 am

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Builds Strategic Portfolio of Industrial Hemp-based Companies

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) is remaining focused on executing its strategic growth plan in the thriving industrial hemp market. An article discussing the company reads: “As a publicly traded company headquartered in British Columbia, Canada, Global Hemp Group is focused on attracting joint venture partners across all sectors of the industrial hemp industries with a commitment to improving quality of life by researching, developing and distributing sustainable materials, products and services produced from hemp and, at the same time, consistently delivering a positive return on investment to shareholders.” To view…

Continue Reading

FridayJun 08, 2018 2:39 pm

CannabisNewsBreaks – Global Hemp Group, Inc. (CSE: GHG) (FRA: GHG) (OTC: GBHPF) Poised to Profit as US Senate Debates Proposed Legislation on Hemp

British Columbia-based hemp cultivation company Global Hemp Group (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) has a lot to gain if the 2018 Farm Bill, which the U.S. Senate is currently debating, passes. The updated bill promotes federal legalization of non-psychoactive industrial hemp in United States. An article discussing the company reads: “Global Hemp Group, Inc. (CSE: GHG) (FRANKFURT: GHG) (OTC: GBHPF) has long had an interest in establishing a strong footing in the industrial hemp industries of Canada and the United States. Its headquarters are situated in Vancouver, British Columbia, where it could be in a prime position to take…

Continue Reading

FridayJun 08, 2018 1:32 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) DehydraTECH™ Delivers Improved Absorption and Application Versatility

Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQB: LXRP) DehydraTECH™ enables improved bioabsorption and versatility in drug delivery applications. A recent article discussing the company’s unique technology reads: “DehydraTECH™ is a unique enabling technology from Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) that increases the absorption rate of edible ingestion, delivering five to 10 times more of active ingredients than traditional edibles. This technology is not a competing technology but rather a complementary layer that provides a versatile range of commercial applications. LXRP is the only company in the world that has been awarded a patent for the improved (oral or ingestible)…

Continue Reading

FridayJun 08, 2018 11:03 am

CannabisNewsBreaks – Pivot Pharmaceuticals Inc.’s (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) Advanced Technologies Drive Product Development

Pivot Pharmaceuticals Inc. (CSE: PVOT) (OTCQB: PVOTF) (FRA: NPAT) is an emergent biopharmaceutical company engaged in the development and commercialization of pharmaceuticals and nutraceuticals that deliver innovative treatments for unmet healthcare needs. An article discussing the company reads: “The advent of modern licensing controls for over-the-counter medications in Canada nearly 15 years ago paved the way for people to pursue health options ranging from traditional Chinese medicines to manufactured vitamins with greater freedom. Caught up in the current were a number of cannabis-based therapies taking advantage of the growing attention paid to the plant’s medicinal properties. Pivot Pharmaceuticals Inc. (CSE:…

Continue Reading

WednesdayJun 06, 2018 2:38 pm

CannabisNewsBreaks – BLOCKStrain Technology Corp. (TSX.V: DNAX) Multi-user Platform Delivers Transparency from Manufacture to Market

BLOCKStrain Technology (TSX.V: DNAX) has developed a blockchain-based genetic registration process that provides verification security for growers and consumers in the cannabis industry. An article discussing the company reads: “BLOCKStrain has adapted the open-source ledger’s technology to provide a cannabis genome-to-sale genetic chain of evidence that provides proof of ownership to brand builders in the multibillion-dollar industry and allows consumers to verify where a product originated and where it has been before landing in their shopping carts. In between the two extremes of the pipeline, distributors, shipping companies and government agencies also have a stake in auditing a product’s wellbeing.…

Continue Reading

FridayJun 01, 2018 3:08 pm

CannabisNewsBreaks – PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) Targets Massive Alternative Medicines Market

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) is devoted to developing preventative medical therapies based on the recognized health benefits of natural substances. An article discussing the company reads: “Grandview Research found that the market for alternative medicines was valued at $40.3 billion at the time of its study three years ago. The report found that 60 percent of the world’s population uses some type of traditional or non-conventional medicine, and a separate report by The National Center for Disease Control found that 20 percent of the United States’ population uses alternative therapies, as noted in a Crystal…

Continue Reading